PolarCool signs its first agreement in the Finnish hockey league
The med-tech company PolarCool AB (publ) makes a strategic breakthrough in Finland. The company has entered into a 2-year agreement with the Finnish professional hockey club KalPa, for the use of the PolarCap® System.
PolarCool develops and markets the product PolarCap® which alleviates the effects of concussion. The primary users of PolarCap® include sports clubs, organizations, and facilities in contact sports such as ice hockey, rugby, and handball, but also other sports with an increased risk of concussion.
The Finnish club KalPa plays in the Finnish top league, Liiga, and will use the PolarCap® System from the beginning of this season in an initial trial period, with the option to continue in a two-year commercial agreement after the evaluation.
KalPa’s CEO Toni Saksman comments:
-As a club, we are looking forward to including the PolarCap® System in our routines around concussions. Working with and against the problems of head injuries is important to us and our players in KalPa. I hope that this is the start of a long-term collaboration with PolarCool.
PolarCool's ambition is for this to be the start of a broader establishment of the PolarCap® System in the Finnish hockey market, and the rest of the Nordic region.
PolarCool's CEO Erik Andersson comments:
-Our first agreement in Finland is very gratifying. We notice that the strengthening clinical results for the treatment are important when the clubs make decisions in Finland, not least for the medically responsible. With this agreement, the hope is that more clubs will follow KalPa and that the PolarCap® System will thus be established as a treatment method on the Finnish hockey market. In the long term, the goal is to obtain a league solution like the one in place in the SHL.
KalPa is a historic ice hockey team from Kuopio and was founded in 1929. Since 2005, KalPa has been one of the top teams in the Finnish league. KalPa is also known for producing top players, such as former NHL stars Kimmo Timonen, Olli Jokinen and Sami Kapanen.
For more information
Erik Andersson – CEO PolarCool AB (publ)
+46 - 738 60 57 00
E-mail: erik.andersson@polarcool.se
About PolarCool AB (publ)
PolarCool AB (publ) is a medical device company that develops, markets, and sells products for sports medicine. The company focuses on treatment of concussive and sub-concussive brain injury with the portable cooling device PolarCap® System. PolarCool AB (publ) is based in Lund, Sweden, and its shares are listed on Spotlight Stock Market.